How big is the South America Beta-Glucan Market?

The South America Beta-Glucan Market size is expected to reach USD 38.40 million in 2024 and grow at a CAGR of 6.21% to reach USD 51.90 million by 2029. Read More

What is the current South America Beta-Glucan Market size?

In 2024, the South America Beta-Glucan Market size is expected to reach USD 38.40 million. Read More

Who are the key players in South America Beta-Glucan Market?

Tate & Lyle PLC, Kerry Group PLC, Biothera Inc., Lesaffre and Koninklijke DSM N.V. are the major companies operating in the South America Beta-Glucan Market. Read More

What years does this South America Beta-Glucan Market cover, and what was the market size in 2023?

In 2023, the South America Beta-Glucan Market size was estimated at USD 36.02 million. The report covers the South America Beta-Glucan Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the South America Beta-Glucan Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

South America Beta-Glucan Market Share

Statistics for the 2023 & 2024 South America Beta-Glucan market share, created by Mordor Intelligence™ Industry Reports. South America Beta-Glucan share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of South America Beta-Glucan Industry

South America beta-glucan market is highly competitive, with several regional and multinational companies competing for leading market positions. These companies focus on research and development activities to enhance their product portfolio and stay competitive. In addition, they are focusing on expanding their exclusive functional food product portfolio by acquiring various raw materials and end-product manufacturing companies, intending to enhance their market position. Some of the major players in the market studied are Tate & Lyle PLC, Biothera Inc., Koninklijke DSM N.V., and Lesaffre, among others.